Myasthenia Gravis News

April 8, 2021April 8, 2021

Single, Low-dose Course of Rituximab Treats MuSK-MG, Pilot Study Suggests

A single, two-day and low-dose course of rituximab can effectively treat patients with muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG) over at least six months, according to a pilot study. The ... Read more

April 6, 2021April 6, 2021

MG Often More Severe and Generalized in Patients With Thymoma, Study Finds

Myasthenia Gravis News

Myasthenia gravis (MG) tends to be more severe and generalized at diagnosis, and myasthenic crises more frequent in patients whose disease is associated with thymoma, an analysis of a patient ... Read more

April 1, 2021April 1, 2021

Cost of Rare Diseases in US? Nearly $1 Trillion in 2019, EveryLife Foundation Finds

Myasthenia Gravis News

As anyone affected by a rare disease knows, treating the illness while trying to go about everyday life is an expensive undertaking. But exactly how expensive — in terms of ... Read more

April 1, 2021April 1, 2021

Too Much Pyridostigmine May Increase Overactive Bladder Issues

Myasthenia Gravis News

High pyridostigmine doses cause overactive bladder issues in people with myasthenia gravis (MG), according to a recent study. Because of this, doctors should take patients’ bladder-related discomfort into account when ... Read more

March 30, 2021March 30, 2021

Immunosuppressants May Be Beneficial to Treat MG Patients With COVID-19

COVID-19 News, Myasthenia Gravis News

In two of three myasthenia gravis (MG) patients who contracted COVID-19, the use of immunosuppressants did not cause an exacerbation or myasthenic crisis, a case study reports, suggesting the treatments ... Read more

March 25, 2021March 25, 2021

Soliris Effective and Safe in Real-world Use, Japanese Study Reports

Myasthenia Gravis News

Soliris (eculizumab) was found in a real-world setting to safely and effectively treat adults with generalized myasthenia gravis (gMG) who had stopped responding to other treatments, according to a post-marketing ... Read more

March 23, 2021March 23, 2021

MG May Mimic Stroke Symptoms, Case Report Suggests

Myasthenia Gravis News

Myasthenia gravis (MG) can mimic the symptoms of a stroke and should not be ruled out even in younger patients, a recent medical case report suggests. The report, “Myasthenia gravis ... Read more

March 18, 2021March 18, 2021

#MDA2021 – Infection Risk Found Unaffected by Long-term Soliris Use

Myasthenia Gravis News

When used over long periods of time, Soliris (eculizumab) does not increase the risk of infections in people with generalized myasthenia gravis (gMG), according to a new analysis of clinical ... Read more

March 16, 2021March 16, 2021

Disease Crisis Linked to Distinct Pro-inflammatory Immune Changes

Myasthenia Gravis News

Myasthenia gravis (MG) crisis, the disease’s most severe state, is associated with pronounced pro-inflammatory cellular and molecular changes, a recent study shows. Notably, several pro-inflammatory immune cells and molecules were ... Read more

March 11, 2021March 11, 2021

Rapid Tapering of Prednisone Safe and Effective for Generalized MG, Trial Finds

Myasthenia Gravis News

Rapid tapering of high-dose prednisone appears to be a feasible, safe, and effective option for people with moderate-to-severe generalized myasthenia gravis on a combination of corticosteroids and immunosuppressants, according to data ... Read more

March 9, 2021March 9, 2021

Pink, Green, Blue and Purple Lights Illuminated World for Rare Disease Day

COVID-19 News, Myasthenia Gravis News

Many diseases have their own awareness color — breast cancer is pink, muscular dystrophy is green, and AIDS is red, for example — but what’s the significance of pink, green, ... Read more

March 9, 2021March 9, 2021

Phase 3 Trial of Zilucoplan Enrolling Adults with Generalized MG

Myasthenia Gravis News

Ra Pharmaceuticals is enrolling adults with generalized myasthenia gravis (gMG) in RAISE, its global and pivotal Phase 3 trial evaluating the safety and efficacy of zilucoplan, the Muscular Dystrophy Association ... Read more

March 5, 2021March 5, 2021

FDA Reviewing Efgartigimod as Possible Treatment for Generalized MG

Myasthenia Gravis News

The U.S. Food and Drug Administration (FDA) is now reviewing an application from Argenx that seeks approval of efgartigimod (ARGX-113) to treat people generalized myasthenia gravis (gMG). An agency decision is ... Read more

March 2, 2021March 2, 2021

MG Patients Should Be Priority for COVID-19 Vaccine, Report Says, Citing Risks

COVID-19 News, Myasthenia Gravis News

People with myasthenia gravis (MG) are at greater risk of being hospitalized or dying from COVID-19 than the general public, and should be prioritized for vaccination, researchers report. COVID-19 vaccines are ... Read more

February 26, 2021February 26, 2021

Generalized MG Patients Needed for UCB’s Global Rozanolixizumab Trial

Myasthenia Gravis News

An international Phase 3 clinical trial assessing the efficacy, safety, and tolerability of rozanolixizumab as a treatment for generalized myasthenia gravis (MG) is currently recruiting participants at 114 study locations. ... Read more